Chewy Beat, Raised Guidance, and Still Fell 7%. The Fight Is Over What the Growth Is Worth

Both camps watched the same quarter. Chewy reported net sales up 7.3% to $3.33 billion, pushed its full-year outlook higher, and yet the stock fell about 7% in the session, adding to a roughly 35% decline so far this year. Bulls see a subscription company proving it can raise prices and deepen margins. Bears see growth that is increasingly bought rather than earned, profit propped up by cost cuts, and a share price that still demands the story continue. The duel is not over whether Chewy had a decent quarter — everyone agrees on that. It is over what that quarter is actually worth at a stock trading near 35 times forward earnings.

The shared facts

Both sides sign their names to the same record from the fiscal second quarter (13 weeks ended August 2, 2026, reported September 9):

• Net sales of $3.33 billion, up 7.3% year over year — but only 5.7% after excluding the SmartPak and Modern Animal acquisitions. Net sales of $3.33 billion increased 7.3 percent year over year or 5.7 percent excluding SmartPak and Modern Animal contributions Net sales landed at the high end of management's guidance range. Q2 total enterprise net sales at the high end of our guidance range of $3.33 billion
• Active customers of 21.705 million, up 3.8%, roughly 43,000 of them from SmartPak. Net sales per active customer rose just 1.9% to $602. Active Customers: increased 3.8% to 21.705 million
• Autoship sales of $2.82 billion, up 9.3%, now 84.6% of total sales versus 83.0% a year earlier.
• Gross margin flat at 30.4%. Adjusted EBITDA margin up 90 basis points to 6.8% on $226.7 million.
• Adjusted diluted EPS of $0.36, up from $0.33; diluted GAAP EPS of $0.20, up from $0.14.
• Quarterly free cash flow fell 15.5% to $89.5 million, on higher capital spending.
• During the first six months, Chewy spent $552.8 million on acquisitions and $400 million buying back its own shares, while cash fell from $860.1 million to $611.0 million and debt rose to $591.7 million. $552.8 million spent on acquisitions; $400.0 million spent on share repurchases

Then the disagreement variables: how durable the Autoship machine is, whether the margin story has room to keep running, and whether the current price already capitalizes both.

Round one: Is Autoship a subscription business or a subscription habit?

The bull's strongest claim is Autoship, Chewy's recurring-delivery program. At 84.6% of sales and growing 9.3% — faster than the 7.3% total — it is the closest thing e-commerce has to a subscription. The bull argues this is a pet-care platform, not discretionary retail: pet owners set the food to auto-reorder, and that recurring base gives visibility into revenue that a shelf-retailer cannot match.

The bear accepts the recurring base but points at the margins of the program's growth. Autoship's 9.3% increase is what pushes total sales up 7.3%, and the difference between them — roughly 1.6 points of reported growth — came from buying businesses (SmartPak, a pet-supplement seller, and Modern Animal, a veterinary chain) rather than from selling more to existing customers. Organic growth excluding acquisitions (SmartPak and Modern Animal) was 5.7% That is how the company itself frames it: strip the newly purchased customers out, and the underlying engine grows at about half the headline rate. The bear's sharper point is that per-customer spending is stalling — net sales per active customer rose just 1.9%, so Chewy is adding $602-a-year customers faster than it is getting existing ones to spend more.

Round to the bull. The recurring mix is real and it is deepening — 84.6% of sales on autoship, up from 83.0%, is a genuine improvement in the quality of the revenue. But the bear's organic-growth number is the concession the bull must carry, because it is the number the valuation is built on.

Round two: Where did the profit come from?

The margin story is the sharpest dispute. Adjusted EBITDA margin expanded 90 basis points to 6.8%, and management raised its full-year revenue and profitability outlook. The bull reads this as operating leverage: a fixed-cost base spread over more autoship sales, and a health-and-pharmacy attach that should carry structural margin upside for years.

The bear reads the same number and asks what moved. Gross margin sat exactly flat at 30.4%. Gross Margin: Flat at 30.4% The expansion came entirely from the operating line — total operating expenses grew about 5.4%, below the 7.3% sales growth. That is cost discipline, not pricing power or a richer product mix. Profit growth was driven by operating leverage (disciplined operating expense control) rather than gross margin expansion Cost control is finite: at some point the expenses Chewy is not growing are opex it no longer needs, and the well runs dry. A margin that rises because you spent less is different from one that rises because customers pay you more.

There is a second cost to this quarter that the bull rarely leads with. Free cash flow fell 15.5% to $89.5 million even as operating cash flow rose, because capital spending roughly doubled. Free Cash Flow: $89.5 million, a 15.5% decline YoY, driven by higher capital expenditures And the balance sheet absorbed both the $552.8 million in acquisitions and the $400 million buyback, with cash down and debt up over the first half. The buyback and the purchases look, on paper, like discipline; funded by a rising debt load while cash falls, they are also a bet the stock and the acquired businesses pay off.

Round to the bear, narrowly. The bull wins that EBITDA margin expanded and guidance went up; the bear wins that the mechanism is expense control plus acquisitions, not product leverage. Cost cuts and bought growth are both real, and both run out faster than a pricing-led margin story.

Round three: What the price already demands

Now make both stories pay rent. The stock sits near $21.60, down 7.2% on the day, with a market capitalization around $8.9 billion and roughly 35 times forward earnings — an enterprise value near $8.3 billion against trailing EBITDA of well under $500 million. For a company growing organic revenue 5.7% to 7.3%, a mid-30s earnings multiple is not a turnaround price; it is a growth price.

Reverse-engineer it. To justify ~35 times forward earnings, the market has to believe Autoship keeps reordering reliably, the health-and-veterinary attach keeps lifting the product mix, and the 90-basis-point EBITDA margin expansion repeats for several more years while the newly acquired businesses integrate and add to profit rather than drag on it. That is the bull's full program. Nothing in this quarter disproves it — but nothing forces it, either. The 7% share drop tells you how little room the market had for anything short of the program running perfectly.

The bull can fairly answer that the bar has already been lowered: the stock is down about 35% year to date and nearly half from its 52-week high of $40.55, so much of the disappointment is behind it. A raised full-year outlook at a reset price is, in the bull's telling, the setup. The bear answers that a de-rated stock can stay de-rated, and that a price at 35 times earnings while gross margin sits flat and organic growth is mid-single-digit is not a margin of safety — it is a contract with management to keep cutting costs and closing deals.

The ruling

The business case goes to the bull. Autoship deepening toward 85% of sales, a raised full-year outlook, and expanding EBITDA margin describe a durable retailer getting more profitable. But the stock call goes to the bear at this price. The quarter's profit came from expense control and its growth from two acquisitions, and the market is capitalizing that at a multiple that requires both to keep running for years. With gross margin flat, per-customer spend up less than 2%, and free cash flow down, the burden of proof sits with anyone paying 35 times forward earnings for a 5.7% organic grower.

The ruling flips on the organic machine, not the headline. Watch the ex-acquisition growth rate and gross margin in the next two quarters (fiscal Q3, reported around December 2026): if organic net sales re-accelerate toward 8% or more, if gross margin moves off 30.4%, and if Autoship keeps outpacing total sales by the current margin while free cash flow turns back up, the bull's platform story is finally showing up in the numbers the valuation is built on. If instead organic growth stays mid-single-digit and gross margin stays flat while the debt-financed buybacks and deals continue, the bear's term — a company buying its own growth — was the accurate one all along. The next report is the evidence event.